Global estimated Disability-Adjusted Life-Years (DALYs) of diarrheal diseases: A systematic analysis of data from 28 years of the global burden of disease study

Abstract

Background Diarrheal disease (DD)-associated mortality has declined since 1990; however, the incidence of DD has experienced a less-pronounced decrease. Thus, it is important to track progress in managing DD by following loss of healthy years. A disability-adjusted life-year (DALY), which combines data on years-of-life lost (YLL) and years-lived with-disability (YLD), is a metric that can track such a burden. Methods and findings Using all 28 years of data in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we compared DD DALYs among different demographic subsets including sex, age, country, and World Bank (WB) income level. We also evaluated DD DALYs as a function of the socio-demographic index (SDI), a measure of a region’s socio-demographic development. On a global level, DD DALYs have decreased by approximately 85.43% from 1990 to 2017. Incidence and prevalence have decreased by 1.53% and 4.45%, respectively. A dramatic decrease in DD DALYs were observed for WB low-income countries, but not for WB high-income constituents. The temporal decrease in DD DALY rates in WB low-income countries was likely driven by a decrease in YLL. Alternatively, temporal increases in both YLL and YLD may have contributed to the apparent lack of progress in WB high-income countries. Regardless of WB income classification, children under the age of five and the elderly were the most vulnerable to DD. In nearly every year from 1990 to 2017, DD DALYs for females were higher than those for males in WB high-income regions, but lower than those for males in WB low-income constituents. The reason for these differences is not known. We also observed that the rate of DD DALYs was highly correlated to SDI regardless of WB income classification. Conclusions To the best of our knowledge, this is the only temporal study of DD DALYs that encompasses all 28 years of data available from the GBD. Overall, our analyses show that temporal reductions in DD DALYs are not equivalent across regions, sexes and age groups. Therefore, careful attention to local and demography-specific risk factors will be necessary to tailor solutions in region- and demography-specific manners.

Access to Water‐Related Services Strongly Modulates Human Development

“…Diarrheal disease is still the most burdensome water and sanitation related disease worldwide (Prüss‐Ustün et al., 2019). Yet, an analysis of the recent global evidence has shown that the DALYs associated to diarrheal disease has decreased from 1990 to 2017 (Karambizi et al., 2021). This is congruent with these results showing a significant trend of increasing water and sanitation access as closely related with higher human development metrics across the 21st century.…”

Nanomaterials to address the genesis of antibiotic resistance in Escherichia coli

“…Predictive statistical modeling of 23 pathogens has been used to estimate the global total deaths associated with and attributable to antimicrobial resistance of bacteria in 2019 to be 4.95 million and 1.27 million, respectively, with E. coli being responsible for most of the deaths with those associated with and attributable to antimicrobial resistant E. coli at 23.4% and 24.3%, respectively ( Fernandez, 2022 ). Even without antimicrobial resistance, E. coli poses a significant health risk, as it is one of the major bacterial species contributing to diarrheal diseases and remains the second biggest killer of children below 5 years old after pneumonia, causing 0.437 million deaths annually ( International Vaccine Access Center, 2020 ; Karambizi et al., 2021 ).…”

Tail-Engineered Phage P2 Enables Delivery of Antimicrobials into Multiple Gut Pathogens

“…Gut pathogenic bacteria that cause diarrhea diseases such as Shigella and Escherichia coli pose a great social and economic burden . In 2016, diarrhea diseases were responsible for 1.3 million deaths worldwide and were listed as the fifth leading cause of death in small children (age below 5 years) and eighth in all ages . Furthermore, the emergence of multidrug-resistant bacteria complicates the treatment of infection, and the limited availability of novel antimicrobial agents urges the need for alternative therapeutic options.…”